HanchorBio Inc. (7827)
Market Closed
29 Jul, 05:30
TWSE TWSE Primary NT$
141. 00
+1
+0.7143%
NT$
18.94B Market Cap
- P/E Ratio
- Div Yield
498,030 Volume
- Eps
NT$ 140
Previous Close Want to track 7827 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
HanchorBio Inc. (7827) Statistics
Valuation metrics
Market Cap 18.94B
Enterprise value 18.17B
Trailing P/E (ttm) -
Forward P/E -
PEG ratio -
Price/Sales (ttm) 60.47
Price/Book (mrq) 24.74
Enterprise Value/Revenue 58.2
Enterprise Value/EBITDA -55.36
Overview
Shares outstanding 130.01M
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 525.75K
Average volume (90 days) 566.09K
Price summary
52-Week low 63.7
52-Week high 187
Beta -
50-Day moving average 135.85
200-Day moving average 105.7
Financials
Fiscal year
Fiscal year ends 31 Dec 2024
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -1.59%
Operating margin 0.39%
Operational effectiveness
Return on assets -0.24%
Return on equity -0.32%
Income Statement
Revenue (ttm) 312.22M
Revenue per share (ttm) 2.78
Quarterly revenue growth (yoy) -1%
Gross profit (ttm) 312.22M
EBITDA -328.27M
Net income to common (ttm) -497.62M
Diluted EPS (ttm) -2.25
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 1.22B
Total cash per share (mrq) 9.35
Total debt (mrq) 102.29M
Total Debt/Equity (mrq) 9.59
Current ratio (mrq) 4.74%
Book value per share (mrq) 5.86
Cash Flow
Cash flow statement -293.33M
Levered free cash flow (LFCF) -276.72M
